Safety and Efficacy of a Strategy of Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-intensity Conditioning for Chemosensitive Relapsed Follicular Lymphoma
Phase of Trial: Phase II
Latest Information Update: 13 Aug 2018
At a glance
- Drugs Rituximab (Primary) ; Cyclophosphamide; Fludarabine; Methotrexate; Tacrolimus
- Indications Follicular lymphoma; Graft-versus-host disease
- Focus Therapeutic Use
- Acronyms RITALLO
- 08 Aug 2018 Status changed from active, no longer recruiting to completed.
- 19 Aug 2016 Planned End Date changed from 1 Aug 2017 to 1 Oct 2017.
- 19 Aug 2016 Planned primary completion date changed from 1 Aug 2017 to 1 Oct 2017.